AtriCure Inc reports results for the quarter ended in December - Earnings Summary

AtriCure

15/02/2024 22:01

* AtriCure Inc  ATRC.OQ  reported a quarterly adjusted loss
of 21
cents​​ per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of -9
cents.  The mean expectation of nine analysts for the quarter
was for a loss of 23 cents per share. Wall Street expected
results to range from -29 cents to -20 cents per share.
    * Revenue rose 21% to $106.54 million from a year ago;
analysts
expected $103.68 million. 
    * AtriCure Inc's reported EPS for the quarter was a loss
of 21
cents​.
    * The company reported a quarterly loss of $9.79 million.
    * AtriCure Inc shares had fallen by 8.8% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for AtriCure Inc is
$54.50 
This summary was machine generated from LSEG data February 15 at
10:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.23          -0.21          Beat
 Sep. 30 2023      -0.31          -0.20          Beat
 Jun. 30 2023      -0.30          -0.11          Beat
 Mar. 31 2023      -0.34          -0.23          Beat